Brent Standridge Net Worth & Insider Trades
Brent Standridge - Chief Operating Officer, Aratana Therapeutics, Inc
What is Brent Standridge's Net Worth?
The current estimated net worth of Aratana Therapeutics, Inc's Chief Operating Officer, Brent Standridge, is estimated to be about $563.06K . Brent Standridge owns about 99,967 units of Aratana Therapeutics, Inc common stock. In the last 2 years at Aratana Therapeutics, Inc, Brent Standridge has sold an estimated value of $106.77K worth.
What is Brent Standridge's Past Insider Trading?
Brent Standridge's largest sale order was 10,000 units , worth over $61.13K on September 27, 2017. In total, Brent Standridge has made about 5 transactions over 2 years of their time at Aratana Therapeutics, Inc. Brent Standridge usually trades in January, with the busiest year in 2017 and 2018. The most recent transaction was a sale order of 10,000 units , worth over $45.64K on June 27, 2018.
Brent Standridge
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Brent Standridge's Salary in 2018?
As Chief Operating Officer of Aratana Therapeutics, Inc, Brent Standridge has a total base salary of $315,000 . Brent Standridge received compensation valued at about $799,804 in 2018 after becoming Chief Operating Officer. The vast majority of their compensation came in the form of stock awards of $191,751 , option awards of $189,953 , other earnings, plans or compensations of $92,100 , and other compensation of $11,000 .
What is Brent Standridge's' Mailing Address?
- Mailing address is C/o Aratana Therapeutics, Inc. 11400 Tomahawk Creek Parkway, Suite 340 Leawood KS 66211 KS
Aratana Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Steven St. Peter, M.D. | 2018 | $528,390 | $654,948 | $649,006 | $247,000 | $11,000 | $2,090,344 |
| Steven St. Peter, M.D. | 2017 | $513,000 | $1,121,998 | $982,434 | $213,000 | $10,800 | $2,841,232 |
| Craig A. Tooman | 2018 | $360,000 | $191,751 | $189,953 | $110,900 | $11,000 | $863,604 |
| Craig A. Tooman | 2017 | $360,000 | $245,412 | $238,970 | $95,100 | $10,800 | $950,282 |
| Brent Standridge | 2018 | $315,000 | $191,751 | $189,953 | $92,100 | $11,000 | $799,804 |
| Brent Standridge | 2017 | $307,500 | $109,072 | $106,209 | $81,300 | $10,800 | $614,881 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1509190/000150919019000027/petx-20190419xdef14a.htm
What are Aratana Therapeutics, Inc's Past Insider Trades?
Aratana Therapeutics, Inc's most recent insider trade came on February 1, 2019 by John C Ayres who sold 3,125 units worth $13.09K . In the last 6 years, insiders at Aratana Therapeutics, Inc have sold an estimated value of $68.33M and bought an estimated value of $12.01M worth of shares. Insider trading is most common in June, with the busiest year in 2014. The most active traders at the company are StSt, PRESIDENT AND CEO, Ernst Heinen, Chief Development Officer, and Julia A Stephanus, CHIEF COMMERCIAL OFFICER .
ARATANA THERAPEUTICS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||